Effects of Fat and Carbohydrates in Obese Men (FATFUNC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01750021 |
Recruitment Status :
Completed
First Posted : December 17, 2012
Last Update Posted : November 30, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Obesity has become a global epidemic, and treating and preventing obesity appears to be one of the world's greatest challenges. The disorder is associated with a wide range of metabolic and hormonal changes, including the development of insulin resistance, changes in adipose tissue function, increased levels of blood lipids, cardiovascular disease and obesity induced fatty liver. Obesity is characterized by inflammation in adipose tissue, altered fat storage capacity and increased exchange of lipids between adipose tissue and blood, and increased secretion of cytokines from adipose tissue. Cytokines are believed to play a central role in the regulation of adipose tissue, the size of adipocytes and other metabolic conditions.
The hepatic synthesis of lipoproteins and interaction with adipose tissue is essential for the body's energy storages. The central role of the liver in energy supply, fat storage and normalization of blood values implies the importance of investigating the interaction between adipose tissue and liver to increase knowledge about the morbidity of obesity. Central obesity and insulin resistance are clear risk factors for the development of fatty liver, but the importance of diet is unclear. The common perception is that fatty liver condition can be improved by a reduction in dietary fat and cholesterols, but the relationship is unclear, and contradictory findings occur in epidemiological studies. It is therefore necessary to better understand the impact of the different macro-nutrients.
The purpose of this study is to determine whether two weight reducing diets with equal calorie levels that contain high or low fat differentially affects the adipose tissue function, distribution of body fat, as well as tissue, blood and urine levels of inflammatory markers, lipids, vitamins, hormones and other substances that may be related to metabolically health.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity Steatosis | Dietary Supplement: High fat low carbohydrate diet Dietary Supplement: Low fat high carbohydrate diet | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Basic Science |
Official Title: | Comparison of Two Weight Reducing Diets in Obese Men |
Study Start Date : | December 2012 |
Actual Primary Completion Date : | January 2014 |
Actual Study Completion Date : | December 2014 |

Arm | Intervention/treatment |
---|---|
Experimental: High fat low carbohydrate diet
High fat low carbohydrate diet
|
Dietary Supplement: High fat low carbohydrate diet
70E% fat, 20E% protein, 10E% carbohydrates |
Experimental: Low fat high carbohydrate diet
Low fat high carbohydrate diet
|
Dietary Supplement: Low fat high carbohydrate diet
20E% fat, 20E% protein, 60E% carbohydrates |
- Changes in adipose tissue [ Time Frame: Baseline and 3 months and 6 months ]CT, body composition, molecular analyses of adipose tissue
- Changes in metabolic parameters [ Time Frame: Baseline and 3 months and 6 months ]Molecular and biochemical analyses of tissue, blood and urine
- Changes in inflammatory parameters [ Time Frame: Baseline and 3 months and 6 months ]Molecular and biochemical analyses of tissue, blood and urine
- Changes in endocrine parameters [ Time Frame: Baseline and 3 months and 6 months ]Molecular and biochemical analyses of tissue, blood and urine
- Changes in metabolic health [ Time Frame: Baseline and 3 months and 6 months ]Clinical and biochemical data
- Changes in adipose tissue distribution [ Time Frame: Baseline and 3 months and 6 months ]Evaluation of adipose tissue distribution by CT
- Changes in steatosis [ Time Frame: Baseline and 3 months and 6 months ]Evaluation by CT

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years to 50 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria.
- Healthy men.
- BMI 30-40.
- Fasting blood glucose < 7 mM.
- Stable body weight last 2 months.
Exclusion Criteria.
- High intake of alcohol.
- Medication affecting glucose or lipid metabolism.
- Allergy towards important food items in the diet.
- Inflammatory bowel disease.
- Surgery or use of antibiotics last 2 months.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01750021
Norway | |
Haukeland University Hospital | |
Bergen, Norway, 5021 |
Principal Investigator: | Gunnar Mellgren, MD PhD | Haukeland University Hospital |
Responsible Party: | Haukeland University Hospital |
ClinicalTrials.gov Identifier: | NCT01750021 |
Other Study ID Numbers: |
2011/2282 |
First Posted: | December 17, 2012 Key Record Dates |
Last Update Posted: | November 30, 2017 |
Last Verified: | November 2017 |
Fatty Liver Liver Diseases Digestive System Diseases |